NEURL2
Basic information
Region (hg38): 20:45888625-45891208
Previous symbols: [ "C20orf163" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEURL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 0 | 18 | 4 | 1 |
Variants in NEURL2
This is a list of pathogenic ClinVar variants found in the NEURL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-45888789-T-G | not specified | Uncertain significance (Aug 02, 2022) | ||
20-45888820-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
20-45888864-A-C | not specified | Uncertain significance (Feb 28, 2023) | ||
20-45888870-G-A | not specified | Uncertain significance (Jul 26, 2023) | ||
20-45890252-C-T | not specified | Uncertain significance (May 30, 2024) | ||
20-45890493-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
20-45890495-C-T | not specified | Uncertain significance (May 08, 2023) | ||
20-45890516-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
20-45890562-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
20-45890565-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
20-45890574-T-C | not specified | Likely benign (Sep 23, 2023) | ||
20-45890585-C-CT | Likely benign (Oct 01, 2023) | |||
20-45890594-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
20-45890601-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
20-45890622-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
20-45890658-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
20-45890723-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
20-45890727-C-A | not specified | Uncertain significance (May 01, 2024) | ||
20-45890843-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
20-45891004-G-A | Combined deficiency of sialidase AND beta galactosidase | Benign (Jun 28, 2018) | ||
20-45891034-T-C | Combined deficiency of sialidase AND beta galactosidase | Uncertain significance (Jun 14, 2016) | ||
20-45891055-G-A | Combined deficiency of sialidase AND beta galactosidase | Uncertain significance (Jun 14, 2016) | ||
20-45891082-TC-T | Combined deficiency of sialidase AND beta galactosidase | Uncertain significance (Jun 14, 2016) | ||
20-45891088-CT-C | Combined deficiency of sialidase AND beta galactosidase | Uncertain significance (Jun 14, 2016) | ||
20-45891092-C-G | Combined deficiency of sialidase AND beta galactosidase | Uncertain significance (Jun 14, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NEURL2 | protein_coding | protein_coding | ENST00000372518 | 2 | 2663 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000134 | 0.421 | 124681 | 5 | 1041 | 125727 | 0.00417 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.306 | 158 | 169 | 0.934 | 0.00000803 | 1794 |
Missense in Polyphen | 51 | 55.076 | 0.92599 | 583 | ||
Synonymous | -0.690 | 82 | 74.4 | 1.10 | 0.00000343 | 643 |
Loss of Function | 0.173 | 6 | 6.48 | 0.926 | 2.82e-7 | 66 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00200 | 0.00191 |
Ashkenazi Jewish | 0.00762 | 0.00747 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00239 | 0.00236 |
European (Non-Finnish) | 0.00732 | 0.00705 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00144 | 0.00137 |
Other | 0.00488 | 0.00473 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an important role in the process of myofiber differentiation and maturation. Probable substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex, which mediates the ubiquitination of proteins. Probably contributes to catalysis through recognition and positioning of the substrate and the ubiquitin-conjugating enzyme. During myogenesis, controls the ubiquitination and degradation of the specific pool of CTNNB1/beta-catenin located at the sarcolemma (By similarity). {ECO:0000250}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.602
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 67.92
Haploinsufficiency Scores
- pHI
- 0.189
- hipred
- N
- hipred_score
- 0.480
- ghis
- 0.438
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.872
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Neurl2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein ubiquitination;intracellular signal transduction;post-translational protein modification
- Cellular component
- cytosol
- Molecular function
- ubiquitin protein ligase activity